Abstract
In light of changing WHO guidelines for HIV treatment, Till Bärnighausen and colleagues consider how large-scale HIV treatment-as-prevention trials can be adapted so that they can remain viable.
Please see later in the article for the Editors' Summary
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Anti-HIV Agents / therapeutic use*
-
Biomedical Research* / ethics
-
CD4 Lymphocyte Count
-
HIV Infections / drug therapy*
-
HIV Infections / prevention & control
-
HIV Infections / transmission
-
Humans
-
Practice Guidelines as Topic*
-
World Health Organization